For immediate release 2 September 2010
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Issue of new ordinary shares
MedicX Fund Limited (the "Company") announces that earlier today it issued for cash 750,000 new ordinary shares of no par value in the Company (the "New Shares"). The issue price per New Share (before expenses) is 72.5 pence.
The net proceeds will be used in further pursuing the investment objectives of the Company.
The New Shares will be admitted to the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange's main market for listed securities pursuant to the block listing application announced by the Company on 26 June 2008.
Following this issue, the Company has 141,144,740 ordinary shares in issue.
End
For further information please contact:
Buchanan Communications +44 (0) 20 7466 5000
Charles Ryland/Lisa Baderoon/George Prassas
MedicX Group +44 (0) 1483 869 500
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 57 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 34 people operating across the UK.
The Company's website address is www.medicxfund.com